Abbott Wins Glucose Monitor Sales Ban On Appeal At UPC
Abbott has persuaded appellate judges at the Unified Patent Court to stop Sinocare selling certain glucose monitoring displays in Europe, proving that its Chinese rival's devices are likely to have infringed...To view the full article, register now.
Already a subscriber? Click here to view full article